Effect of Low-Dose Dobutamine Infusion on N-Terminal Pro-B-Type Natriuretic Peptide in At-Risk Patients With Acute Myocardial Infarction (DOBERMANN-D): A Randomized Clinical Trial - PubMed
2 days ago
- #cardiology
- #myocardial infarction
- #clinical trial
- Study examines the effect of low-dose dobutamine infusion on N-Terminal Pro-B-Type Natriuretic Peptide (NT-proBNP) in at-risk patients with acute myocardial infarction (AMI).
- Randomized clinical trial named DOBERMANN-D.
- Supported by multiple foundations including Novo Nordisk Foundation, Helge Peetz and Verner Peetz and Hustru Vilma Peetz Foundation, and others.
- Key authors disclosed research grants and advisory roles with pharmaceutical companies like Novo Nordisk, Abbott Vascular, and Boston Scientific.
- Primary keywords include acute myocardial infarction, cardiogenic shock, dobutamine, and hemodynamic effects.